Tatsuki R Kataoka

15PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersObstetrics and gynaecologyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 16, 2026
Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in HER2-positive breast cancer.

|Sep 18, 2025
Aberrant Expression of Gonadotropin-Releasing Hormone Receptor in Human Mast Cells Enhances the Recruitments of Trophoblasts and NK Cells.

Takashi Matsuzaki, Hiroaki Hamaguchi, Ken R Ito

|May 20, 2024
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).

Toshimi Takano, Norikazu Masuda, Mitsuya Ito

|Feb 24, 2024
A Novel Hemocyte-Derived Peptide and Its Possible Roles in Immune Response of Ciona intestinalis Type A.

Shin Matsubara, Rin Iguchi, Michio Ogasawara

|Jan 17, 2024
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.

Chowdhury Arif Jahangir, David B Page, Glenn Broeckx

|Aug 23, 2023
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

Jeppe Thagaard, Glenn Broeckx, David B Page

Pageof 3

Frequent Collaborators

3 joint publications

David B Page

3 joint publications

Anita Grigoriadis

3 joint publications

Jorge S Reis-Filho

3 joint publications

Steven N Hart